partnering

News

Novartis returns PD-1 antibody rights to BeiGene

BeiGene confirmed today that Novartis has pulled out of a partnership on PD-1 inhibitor tislelizumab, two and half years after paying $650 million upfront for ex-China rig

News

AZ's Alexion inks wide-ranging AI agreement with Verge

AstraZeneca has made a sizeable play in applying artificial intelligence to drug discovery in its rare disease unit Alexion, partnering with Verge Genomics in a deal that

News

Seagen partners Nurix on 'degrader-antibody conjugates'

Seagen hasn't let a pending acquisition by Pfizer interrupt its business development activities, adding to its pipeline with a wide-ranging partnership with Nurix Therapeu

News

J&J pulls out of Idorsia deal for hypertension drug

Idorsia has lost Johnson & Johnson's Janssen Biotech unit as the partner for its aprocitentan candidate for resistant hypertension, following a likely delay in the FDA

News

AI specialist Intelligent Omics bags J&J deal

UK artificial intelligence (AI) specialist Intelligent Omics has entered into a research collaboration with Johnson & Johnson, within weeks of joining the big pharma's

News

Google builds in biotech AI with Ginkgo alliance

Google Cloud and Ginkgo Bioworks have started a five-year partnership to bring artificial intelligence to biotech in areas including genomics, protein studies, and infecti

Novartis returns PD-1 antibody rights to BeiGene

AZ's Alexion inks wide-ranging AI agreement with Verge

Seagen partners Nurix on 'degrader-antibody conjugates'

J&J pulls out of Idorsia deal for hypertension drug

AI specialist Intelligent Omics bags J&J deal

Google builds in biotech AI with Ginkgo alliance

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

partnering

Editor's Picks